Special conference on 'growth factors, development and cancerBROGGINI, M.Annals of oncology. 1994, Vol 5, Num 7, pp 575-577, issn 0923-7534Article

SUBCELLULAR DISTRIBUTION OF ADRIAMYCIN IN THE LIVER AND TUMOR OF 3LL-BEARING MICE = DISTRIBUTION INFRACELLULAIRE DE L'ADRIAMYCINE DANS LE FOIE ET LA TUMEUR DE SOURIS PORTEUSES DE LA TUMEUR 3LLBROGGINI M; GHERSA P; GRAZIA DONELLI M et al.1983; EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY; ISSN 0277-5379; GBR; DA. 1983; VOL. 19; NO 3; PP. 419-426; ABS. ENG; BIBL. 48 REF.; GRAPHArticle

PI3K/AKT/mTOR Inhibitors In Ovarian CancerMAZZOLETTI, M; BROGGINI, M.Current medicinal chemistry. 2010, Vol 17, Num 36, pp 4433-4447, issn 0929-8673, 15 p.Article

STUDIES ON THE COMPARATIVE DISTRIBUTION AND BILIARY EXCRETION OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN MICE AND RATSBROGGINI M; COLOMBO T; MARTINI A et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 8-9; PP. 897-904; BIBL. 26 REF.Article

DIFFERENTIAL DISTRIBUTION OF ANTITUMOR AGENTS IN PRIMARY AND SECONDARY TUMORS.DONELLI MG; COLOMBO T; BROGGINI M et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 7; PP. 1319-1324; BIBL. 27 REF.Article

Modulation of transcription factor-DNA interactions by anticancer drugsBROGGINI, M; D'INCALCI, M.Anti-cancer drug design. 1994, Vol 9, Num 4, pp 373-387, issn 0266-9536Article

HEXAMETHYLMELAMINE AND PENTAMETHYLMELAMINE TISSUE DISTRIBUTION IN M5076/73A OVARIAN CANCER-BEARING MICEBROGGINI M; ROSSI C; COLOMBO T et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 1; PP. 127-133; BIBL. 16 REF.Article

DIFFERENTIAL ADRIAMYCIN^REG. DISTRIBUTION TO BLOOD COMPONENTSCOLOMBO T; BROGGINI M; GARATTINI S et al.1981; EUR. J. DRUG METAB. PHARMACOKINET.; ISSN 0378-7966; CHE; DA. 1981; VOL. 6; NO 2; PP. 115-122; BIBL. 34 REF.Article

DISTRIBUTION AND ANTITUMOR ACTIVITY OF ADRIAMYCIN GIVEN IN A HIGH-DOSE AND A REPEATED LOW-DOSE SCHEDULE TO MICE.PACCIARINI MA; BARBIERI B; COLOMBO T et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 5; PP. 791-800; BIBL. 32 REF.Article

EARLY PHASE PHARMACOKINETICS OF DOXORUBICIN (ADRIAMYCIN) IN PLASMA OF CANCER PATIENTS DURING SINGLE- OR MULTIPLE-DRUG THERAPYPIAZZA E; DONELLI MG; BROGGINI M et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 8-9; PP. 845-854; BIBL. 29 REF.Article

FLOW-CYTOMETRIC ANALYSIS OF DNA DISTRIBUTION AFTER VP 16-213 TREATMENT OF LEWIS LUNG CARCINOMAERBA E; UBEZIO P; COLOMBO T et al.1983; CANCER CHEMOTHERAPY AND PHARMACOLOGY; ISSN 0344-5704; DEU; DA. 1983; VOL. 10; NO 3; PP. 208-211; BIBL. 16 REF.Article

PHARMACOKINETICS OF HEXAMETHYLMELAMINE AND PENTAMETHYLMELAMINE IN MICEBROGGINI M; COLOMBO T; D'INCALCI M et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 7-8; PP. 669-672; BIBL. 10 REF.Article

Flurbiprofen versus ASA in influenza symptomatology: a double-blind studyBROGGINI, M; BOTTA, V; BENVENUTI, C et al.International journal of clinical pharmacology research. 1986, Vol 6, Num 6, pp 485-488, issn 0251-1649Article

A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the kneeBIANCHI, M; BROGGINI, M.Drugs (Basel). 2003, Vol 63, pp 37-46, issn 0012-6667, 10 p., SUP1Conference Paper

Pharmacokinetics of fluocinolone acetonide in patch versus cream formulationsBROGGINI, M; BENVENUTI, C; BOTTA, V et al.International journal of clinical pharmacology research. 1991, Vol 11, Num 1, pp 17-21, issn 0251-1649, 5 p.Article

Effect of G:C→A:T transition, potentially arising from O⁶-guanine alkylation, in the transcription regulation of c-fos serum response elementBONFANTI, M; COLELLA, G; BROGGINI, M et al.Anticancer research. 1997, Vol 17, Num 3C, pp 2019-2024, issn 0250-7005Article

Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53FAINA VIKHANSKAYA; ERBA, E; D'INCALCI, M et al.Nucleic acids research. 1994, Vol 22, Num 6, pp 1012-1017, issn 0305-1048Article

Attività del centro di riabilitazione visiva per pazienti ipovedenti della divisione oftalmica dell'ospedale multizonale di Circolo-Varese = Performance of the rehabilitation center of ophthalmology department in the hospital of VareseBROGGINI, M; TONDINI, L; CRISCITO, M et al.Annali di ottalmologia e clinica oculistica. 1993, Vol 119, Num 5, pp 397-400, issn 0003-4665Article

Retinoblastoma ad insorgenza tardiva. Caso clinico = Tardive onset retinoblastoma. Clinical reportCRISCITO, M; CERRI, L; BROGGINI, M et al.Annali di ottalmologia e clinica oculistica. 1993, Vol 119, Num 5, pp 401-404, issn 0003-4665Article

Different pharmacological approaches to the treatment of acute biliary colicGROSSI, E; BROGGINI, M; QUARANTA, M et al.Current therapeutic research. 1986, Vol 40, Num 5, pp 876-882, issn 0011-393XArticle

RAS/RAF/MEK Inhibitors in OncologyRUSCONI, P; CAIOLA, E; BROGGINI, M et al.Current medicinal chemistry. 2012, Vol 19, Num 8, pp 1164-1176, issn 0929-8673, 13 p.Article

Sensitivity and cellular response to different anticancer agents of a human ovarian cancer cell line expressing wild-type, mutated or no p53GRANIELA SIRE, E. A; VIKHANSKAYA, F; BROGGINI, M et al.Annals of oncology. 1995, Vol 6, Num 6, pp 589-593, issn 0923-7534Article

Differential inhibition of the DNA binding of transcription factors NFκB and OTF-1 by nitrogen mustard and quinacrine mustard : transcriptional implicationsFABBRI, S; PRONTERA, C; BROGGINI, M et al.Carcinogenesis (New York. Print). 1993, Vol 14, Num 9, pp 1963-1967, issn 0143-3334Article

Effects of DNA damaging agents on gene expression in two human cancer cell linesVIKHANSKAYA, F; D'INCALCI, M; BROGGINI, M et al.Cellular and molecular biology. 1993, Vol 39, Num 8, pp 855-862, issn 0145-5680Article

O⁶-methylguanine inhibits the binding of transcription factors to DNABONFANTI, M; BROGGINI, M; PRONTERA, C et al.Nucleic acids research. 1991, Vol 19, Num 20, pp 5739-5742, issn 0305-1048Article